Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
University Hospital, Tours
Sunnybrook Health Sciences Centre
Centre Hospitalier Universitaire de Besancon
Centre Hospitalier Universitaire de Besancon
Assistance Publique - Hôpitaux de Paris
Centre Oscar Lambret
Centre Oscar Lambret
University of Aarhus
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Assistance Publique - Hôpitaux de Paris
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
University Hospital, Clermont-Ferrand
Abramson Cancer Center at Penn Medicine
Hoffmann-La Roche
University of California, San Francisco
Massachusetts General Hospital
Institute of Oncology Ljubljana
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Poitiers University Hospital